Statistical Analysis Plans

• Corticosteroid Domain Statistical Analysis Plan

• Corticosteroid Doman-Specific Appendix for manuscript

• COVID-19 Antiviral Domain Statistical Analysis Plan

• Tocilizumab and Sarilumab Statistical Analysis Plan

• COVID-19 Immune Modulation Domain Statistical Analysis Plan

• Therapeutic Anticoagulation Domain Statistical Analysis Plan (Severe State)

• Therapeutic Anticoagulation Domain Statistical Analysis Plan (Moderate State)

• COVID-19 Immune Modulation (II) Domain Statistical Analysis Plan

• Immunoglobulin Domain Statistical Analysis Plan

• Antiplatelet Domain Statistical Analysis Plan

• Simvastatin Domain Statistical Analysis Plan

• ACE2 RAS Domain Statistical Analysis Plan

• Vitamin C Doman-Specific Appendix for manuscript

• Vitamin C Statistical Analysis Plan (PISOP Strata)

• Long-term survival and disability Statistical Analysis Plan

• Anticoagulation Domain Statistical Analysis Plan (Continuation of TAC)

• COVID-19 Antiviral Domain Statistical Analysis Plan (Ivermectin)

• COVID-19 Immune Modulation 2 Domain Statistical Analysis Plan

• IL-6 (Tocilizumab and Sarilumab) Biomarker Analysis Statistical Analysis Plan

• Corticosteroid Domain Statistical Analysis Plan (Fixed-Dose Hydrocortisone)

• Pandemic Infection Suspected or Proven Comprehensive Statistical Analysis Plan

• COVID-19 Anticoagulation Domain Statistical Analysis Plan

• Antibiotic Domain Statistical Analysis Plan (PISOP Strata)

• Macrolide Domain Statistical Analysis Plan (PISOP Strata)

• Ferritin and suPAR Biomarker Statistical Analysis Plan

• Cysteamine Domain Statistical Analysis Plan

• Ethical, Administrative, Regulatory and Logistical (EARL) Questions on Consent Statistical Analysis Plan

• Vitamin C Statistical Analysis Plan (PINSNP Strata)

• Long-term survival and disability (2) Statistical Analysis Plan

• Influenza Antiviral Domain Statistical Analysis Plan